{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:50:34Z","timestamp":1785487834508,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Beijing, China","award":["7214223"],"award-info":[{"award-number":["7214223"]}]},{"name":"Natural Science Foundation of Beijing, China","award":["7212027"],"award-info":[{"award-number":["7212027"]}]},{"name":"Beijing Hospitals Authority Youth Programme","award":["QML20210601"],"award-info":[{"award-number":["QML20210601"]}]},{"name":"National Key Research and Development Program of China","award":["2017YFC0908800"],"award-info":[{"award-number":["2017YFC0908800"]}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["PXM2020_026272_000002"],"award-info":[{"award-number":["PXM2020_026272_000002"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The atherogenic index of plasma (AIP) is a novel biomarker associated with atherosclerosis, and an important risk factor for atherosclerosis, but its relation with cardiovascular prognosis in prediabetic patients with unstable angina pectoris (UAP) is still uncertain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 1096 prediabetic patients with UAP who were subjected to follow-up for a maximum of 30 months, with cardiac death, refractory angina, and non-fatal myocardial infarction (MI) being the primary cardiovascular endpoints.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A significantly increased AIP was observed for the group with primary cardiovascular endpoints. Kaplan\u2013Meier curves corresponding to these endpoints revealed pronounced differences between these two AIP groups (Log-rank <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Multivariate Cox proportional hazards analyses highlighted AIP as being independent related to this primary endpoint (HR 1.308, 95% CI: 1.213\u20131.412, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). AIP addition to the baseline risk model improved the prediction of the primary endpoint (AUC: baseline model, 0.622, vs. baseline model\u2009+\u2009AIP, 0.739, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AIP could be used to predict cardiovascular events in prediabetic individuals with UAP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-023-01443-x","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T05:02:56Z","timestamp":1693458176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris"],"prefix":"10.1186","volume":"23","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunxun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"1","key":"1443_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/eurheartj\/ehz767","volume":"41","author":"PR Lawler","year":"2020","unstructured":"Lawler PR, Kotrri G, Koh M, et al. Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies. Eur Heart J. 2020;41(1):86\u201394. https:\/\/doi.org\/10.1093\/eurheartj\/ehz767.","journal-title":"Eur Heart J"},{"issue":"9","key":"1443_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.mayocp.2019.03.028","volume":"94","author":"PP Toth","year":"2019","unstructured":"Toth PP, Philip S, Hull M, Granowitz C. Association of elevated triglycerides with increased Cardiovascular Risk and direct costs in statin-treated patients. Mayo Clin Proc. 2019;94(9):1670\u201380. https:\/\/doi.org\/10.1016\/j.mayocp.2019.03.028.","journal-title":"Mayo Clin Proc"},{"key":"1443_CR3","doi-asserted-by":"publisher","first-page":"7027624","DOI":"10.1155\/2018\/7027624","volume":"2018","author":"MS Bo","year":"2018","unstructured":"Bo MS, Cheah WL, Lwin S, Moe Nwe T, Win TT, Aung M. Understanding the relationship between Atherogenic Index of plasma and Cardiovascular Disease Risk factors among staff of an University in Malaysia. J Nutr Metab. 2018;2018:7027624. https:\/\/doi.org\/10.1155\/2018\/7027624.","journal-title":"J Nutr Metab"},{"issue":"7","key":"1443_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138. https:\/\/doi.org\/10.1016\/s0009-9120(01)00263-6.","journal-title":"Clin Biochem"},{"issue":"1","key":"1443_CR5","first-page":"64","volume":"52","author":"M Dobi\u00e1sov\u00e1","year":"2006","unstructured":"Dobi\u00e1sov\u00e1 M. AIP\u2013atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52(1):64\u201371.","journal-title":"Vnitr Lek"},{"issue":"1","key":"1443_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2015.06.057","volume":"242","author":"R Quispe","year":"2015","unstructured":"Quispe R, Manalac RJ, Faridi KF, et al. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio to the remainder of the lipid profile: the very large database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015;242(1):243\u201350. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.06.057.","journal-title":"Atherosclerosis"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"1273042","DOI":"10.1155\/2017\/1273042","volume":"2017","author":"EA Ivanova","year":"2017","unstructured":"Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small dense low-density lipoprotein as Biomarker for atherosclerotic Diseases. Oxid Med Cell Longev. 2017;2017:1273042. https:\/\/doi.org\/10.1155\/2017\/1273042.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1443_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","volume":"58","author":"B Verg\u00e8s","year":"2015","unstructured":"Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886\u201399. https:\/\/doi.org\/10.1007\/s00125-015-3525-8.","journal-title":"Diabetologia"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"7197054","DOI":"10.1155\/2020\/7197054","volume":"2020","author":"C Wang","year":"2020","unstructured":"Wang C, Du Z, Ye N, et al. Using the Atherogenic Index of plasma to Estimate the prevalence of ischemic stroke within a General Population in a rural area of China. Biomed Res Int. 2020;2020:7197054. https:\/\/doi.org\/10.1155\/2020\/7197054.","journal-title":"Biomed Res Int"},{"issue":"10","key":"1443_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/00033197211012129","volume":"72","author":"K Zhou","year":"2021","unstructured":"Zhou K, Qin Z, Tian J, Cui K, Yan Y, Lyu S. The Atherogenic Index of plasma: a powerful and Reliable Predictor for Coronary Artery Disease in patients with type 2 diabetes. Angiology. 2021;72(10):934\u201341. https:\/\/doi.org\/10.1177\/00033197211012129.","journal-title":"Angiology"},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","volume":"33 Suppl 1Suppl","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus [published correction appears in Diabetes Care. 2010;33(4):e57]. Diabetes Care. 2010;33 Suppl 1Suppl 1:S62\u20139. https:\/\/doi.org\/10.2337\/dc10-S062.","journal-title":"Diabetes Care"},{"issue":"21","key":"1443_CR12","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1001\/jama.263.21.2893","volume":"263","author":"SM Haffner","year":"1990","unstructured":"Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263(21):2893\u20138. https:\/\/doi.org\/10.1001\/jama.263.21.2893.","journal-title":"JAMA"},{"issue":"6","key":"1443_CR13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.pcd.2020.07.007","volume":"14","author":"X Zhu","year":"2020","unstructured":"Zhu X, Chen Z, Yang P, Liu L, Wu L, Wang Y. The association of subclinical atherosclerosis with prediabetes is stronger in people with dyslipidaemia than in those with normoglycaemia: a cross-sectional study in chinese adults. Prim Care Diabetes. 2020;14(6):760\u20137. https:\/\/doi.org\/10.1016\/j.pcd.2020.07.007.","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"1443_CR14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/nu12051250","volume":"12","author":"W Reyes-Ferrada","year":"2020","unstructured":"Reyes-Ferrada W, Solis-Urra P, Plaza-D\u00edaz J, et al. Cardiorespiratory Fitness, Physical Activity, Sedentary Time and its Association with the Atherogenic Index of plasma in chilean adults: influence of the Waist circumference to height ratio. Nutrients. 2020;12(5):1250. https:\/\/doi.org\/10.3390\/nu12051250.","journal-title":"Nutrients"},{"issue":"Suppl 1","key":"1443_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):15\u2013S33. https:\/\/doi.org\/10.2337\/dc21-S002.","journal-title":"Diabetes Care"},{"issue":"12","key":"1443_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/clc.23896","volume":"45","author":"H Yao","year":"2022","unstructured":"Yao H, Guo Q, Cheng Y, Zhu T, Ma Q, Zhou Y. Predictors and morphological properties of culprit healed plaques in patients with angina pectoris. Clin Cardiol. 2022;45(12):1199\u2013210. https:\/\/doi.org\/10.1002\/clc.23896.","journal-title":"Clin Cardiol"},{"issue":"3","key":"1443_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of Acute Coronary Syndromes in patients presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315. https:\/\/doi.org\/10.1093\/eurheartj\/ehv320.","journal-title":"Eur Heart J"},{"issue":"1","key":"1443_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jacl.2016.10.014","volume":"11","author":"MK Edwards","year":"2017","unstructured":"Edwards MK, Blaha MJ, Loprinzi PD. Influence of sedentary behavior, physical activity, and cardiorespiratory fitness on the atherogenic index of plasma. J Clin Lipidol. 2017;11(1):119\u201325. https:\/\/doi.org\/10.1016\/j.jacl.2016.10.014.","journal-title":"J Clin Lipidol"},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2018.09.016","volume":"284","author":"M Mazidi","year":"2019","unstructured":"Mazidi M, Katsiki N, Mikhailidis DP, Banach M. Association of ideal cardiovascular health metrics with serum uric acid, inflammation and atherogenic index of plasma: a population-based survey. Atherosclerosis. 2019;284:44\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.09.016.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1443_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1123\/jpah.2016-0389","volume":"16","author":"M Edwards","year":"2019","unstructured":"Edwards M, Loprinzi P. The Dose-Response Association between reported moderate to vigorous intensity physical activity and atherogenic index of plasma: NHANES, 1999\u20132006. J Phys Act Health. 2019;16(5):368\u201370. https:\/\/doi.org\/10.1123\/jpah.2016-0389.","journal-title":"J Phys Act Health"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"1765835","DOI":"10.1155\/2018\/1765835","volume":"2018","author":"Z Li","year":"2018","unstructured":"Li Z, Huang Q, Sun L, Bao T, Dai Z. Atherogenic index in type 2 diabetes and its relationship with chronic microvascular complications. Int J Endocrinol. 2018;2018:1765835. https:\/\/doi.org\/10.1155\/2018\/1765835.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1443_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pcd.2014.03.007","volume":"9","author":"XW Zhu","year":"2015","unstructured":"Zhu XW, Deng FY, Lei SF. Meta-analysis of Atherogenic Index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Prim Care Diabetes. 2015;9(1):60\u20137. https:\/\/doi.org\/10.1016\/j.pcd.2014.03.007.","journal-title":"Prim Care Diabetes"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/2277-9175.188489","volume":"5","author":"M Pourfarzam","year":"2016","unstructured":"Pourfarzam M, Zadhoush F, Sadeghi M. The difference in correlation between insulin resistance index and chronic inflammation in type 2 diabetes with and without metabolic syndrome. Adv Biomed Res. 2016;5:153. https:\/\/doi.org\/10.4103\/2277-9175.188489.","journal-title":"Adv Biomed Res"},{"issue":"11","key":"1443_CR24","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.numecd.2019.07.006","volume":"29","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang X, Li X, Feng J, Chen X. Association of metabolic syndrome with atherogenic index of plasma in an urban chinese population: a 15-year prospective study. Nutr Metab Cardiovasc Dis. 2019;29(11):1214\u20139. https:\/\/doi.org\/10.1016\/j.numecd.2019.07.006.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"1443_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12944-020-01387-4","volume":"19","author":"MS Moussavi Javardi","year":"2020","unstructured":"Moussavi Javardi MS, Madani Z, Movahedi A, Karandish M, Abbasi B. The correlation between dietary fat quality indices and lipid profile with atherogenic index of plasma in obese and non-obese volunteers: a cross-sectional descriptive-analytic case-control study. Lipids Health Dis. 2020;19(1):213. https:\/\/doi.org\/10.1186\/s12944-020-01387-4.","journal-title":"Lipids Health Dis"},{"key":"1443_CR26","doi-asserted-by":"crossref","unstructured":"NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA. 1993;269(4):505\u2013510.","DOI":"10.1001\/jama.269.4.505"},{"issue":"1","key":"1443_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12944-018-0828-z","volume":"17","author":"TT Wu","year":"2018","unstructured":"Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197. https:\/\/doi.org\/10.1186\/s12944-018-0828-z.","journal-title":"Lipids Health Dis"},{"issue":"7","key":"1443_CR28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","volume":"114","author":"A Kawakami","year":"2006","unstructured":"Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation. 2006;114(7):681\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.622514.","journal-title":"Circulation"},{"issue":"5","key":"1443_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/DMA-2011-0832","volume":"31","author":"Y Huang","year":"2011","unstructured":"Huang Y, Hu Y, Mai W, et al. Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease. Dis Markers. 2011;31(5):295\u2013301. https:\/\/doi.org\/10.3233\/DMA-2011-0832.","journal-title":"Dis Markers"},{"issue":"2","key":"1443_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/FJC.0b013e318294998d","volume":"62","author":"RF Jacob","year":"2013","unstructured":"Jacob RF, Walter MF, Self-Medlin Y, Mason RP. Atorvastatin active metabolite inhibits oxidative modification of small dense low-density lipoprotein. J Cardiovasc Pharmacol. 2013;62(2):160\u20136. https:\/\/doi.org\/10.1097\/FJC.0b013e318294998d.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"1443_CR31","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1373\/clinchem.2004.031757","volume":"50","author":"MH Tan","year":"2004","unstructured":"Tan MH, Johns D, Glazer NB. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem. 2004;50(7):1184\u20138. https:\/\/doi.org\/10.1373\/clinchem.2004.031757.","journal-title":"Clin Chem"},{"issue":"2","key":"1443_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.33549\/physiolres.930565","volume":"54","author":"M Dobi\u00e1sov\u00e1","year":"2005","unstructured":"Dobi\u00e1sov\u00e1 M, Urbanov\u00e1 Z, Sam\u00e1nek M. Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiol Res. 2005;54(2):159\u201365.","journal-title":"Physiol Res"},{"issue":"37","key":"1443_CR33","doi-asserted-by":"publisher","first-page":"e8058","DOI":"10.1097\/MD.0000000000008058","volume":"96","author":"G Cai","year":"2017","unstructured":"Cai G, Shi G, Xue S, Lu W. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the chinese Han population. Med (Baltim). 2017;96(37):e8058. https:\/\/doi.org\/10.1097\/MD.0000000000008058.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1443_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12944-020-01317-4","volume":"19","author":"JS Nam","year":"2020","unstructured":"Nam JS, Kim MK, Nam JY, et al. Association between atherogenic index of plasma and coronary artery calcification progression in korean adults. Lipids Health Dis. 2020;19(1):157. https:\/\/doi.org\/10.1186\/s12944-020-01317-4.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1443_CR35","doi-asserted-by":"publisher","first-page":"21324","DOI":"10.1038\/s41598-020-78350-x","volume":"10","author":"KB Won","year":"2020","unstructured":"Won KB, Han D, Lee JH, et al. Atherogenic index of plasma and coronary artery calcification progression beyond traditional risk factors according to baseline coronary artery calcium score. Sci Rep. 2020;10(1):21324. https:\/\/doi.org\/10.1038\/s41598-020-78350-x.","journal-title":"Sci Rep"},{"key":"1443_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2021.03.009","volume":"324","author":"KB Won","year":"2021","unstructured":"Won KB, Heo R, Park HB, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46\u201351. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.03.009.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1443_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.mayocp.2016.12.018","volume":"92","author":"MK Edwards","year":"2017","unstructured":"Edwards MK, Blaha MJ, Loprinzi PD. Atherogenic index of plasma and Triglyceride\/High-Density lipoprotein cholesterol ratio Predict Mortality Risk Better Than individual cholesterol risk factors, among an older Adult Population. Mayo Clin Proc. 2017;92(4):680\u20131. https:\/\/doi.org\/10.1016\/j.mayocp.2016.12.018.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1443_CR38","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.advms.2021.09.003","volume":"66","author":"M Sadeghi","year":"2021","unstructured":"Sadeghi M, Heshmat-Ghahdarijani K, Talaei M, Safaei A, Sarrafzadegan N, Roohafza H. The predictive value of atherogenic index of plasma in the prediction of cardiovascular events; a fifteen-year cohort study. Adv Med Sci. 2021;66(2):418\u201323. https:\/\/doi.org\/10.1016\/j.advms.2021.09.003.","journal-title":"Adv Med Sci"},{"issue":"10","key":"1443_CR39","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.numecd.2020.05.028","volume":"30","author":"S Rizza","year":"2020","unstructured":"Rizza S, Longo S, Piciucchi G, et al. Carotid intimal medial thickness in rotating night shift is related to IL1\u03b2\/IL6 axis. Nutr Metab Cardiovasc Dis. 2020;30(10):1826\u201332. https:\/\/doi.org\/10.1016\/j.numecd.2020.05.028.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"1443_CR40","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/clc.23450","volume":"43","author":"KB Won","year":"2020","unstructured":"Won KB, Jang MH, Park EJ, et al. Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: an observational cohort study. Clin Cardiol. 2020;43(12):1398\u2013404. https:\/\/doi.org\/10.1002\/clc.23450.","journal-title":"Clin Cardiol"},{"issue":"1","key":"1443_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-021-01393-5","volume":"20","author":"L Fu","year":"2021","unstructured":"Fu L, Zhou Y, Sun J, et al. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):201. https:\/\/doi.org\/10.1186\/s12933-021-01393-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"1443_CR42","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.3390\/nu13093231","volume":"13","author":"JJ Kim","year":"2021","unstructured":"Kim JJ, Yoon J, Lee YJ, Park B, Jung DH. Predictive value of the Atherogenic Index of plasma (AIP) for the risk of Incident Ischemic Heart Disease among non-diabetic Koreans. Nutrients. 2021;13(9):3231. https:\/\/doi.org\/10.3390\/nu13093231.","journal-title":"Nutrients"},{"key":"1443_CR43","doi-asserted-by":"publisher","unstructured":"Shi Y, Wen M. Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011\u20132018 population. Cardiovasc Diabetol. 2023;22(1):19. Published 2023 Jan 30. https:\/\/doi.org\/10.1186\/s12933-023-01740-8.","DOI":"10.1186\/s12933-023-01740-8"},{"issue":"2","key":"1443_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/07435800.2015.1076454","volume":"41","author":"GS Keerthi","year":"2016","unstructured":"Keerthi GS, Pal P, Pal GK, Sahoo JP, Sridhar MG, Balachander J. Attenuated baroreflex sensitivity in normotensive prediabetes and diabetes in indian adults. Endocr Res. 2016;41(2):89\u201397. https:\/\/doi.org\/10.3109\/07435800.2015.1076454.","journal-title":"Endocr Res"},{"key":"1443_CR45","doi-asserted-by":"publisher","unstructured":"Mahat RK, Singh N, Rathore V, Gupta A, Shah RK. Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India. Med Sci (Basel). 2018;6(3):55. Published 2018 Jul 5. https:\/\/doi.org\/10.3390\/medsci6030055.","DOI":"10.3390\/medsci6030055"},{"issue":"8","key":"1443_CR46","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2174\/1871530320666200503052226","volume":"20","author":"MM El-Eshmawy","year":"2020","unstructured":"El-Eshmawy MM, Gad DF, El-Baiomy AA. Elevated serum levels of Ischemia Modified Albumin and Malondialdehyde are related to Atherogenic Index of plasma in a cohort of Prediabetes. Endocr Metab Immune Disord Drug Targets. 2020;20(8):1347\u201354. https:\/\/doi.org\/10.2174\/1871530320666200503052226.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"10","key":"1443_CR47","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa2208335","volume":"387","author":"DW Park","year":"2022","unstructured":"Park DW, Kang DY, Ahn JM, et al. Routine functional testing or Standard Care in High-Risk patients after PCI. N Engl J Med. 2022;387(10):905\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2208335.","journal-title":"N Engl J Med"},{"issue":"15","key":"1443_CR48","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa1915922.","journal-title":"N Engl J Med"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-023-01443-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-023-01443-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:11:53Z","timestamp":1700226713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-023-01443-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1186\/s12902-023-01443-x","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"29 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the tenants of the Declaration of Helsinki and was approved by the Institutional Ethics Committee of Anzhen Hospital. All patients provided written informed consent for participation in the present study. The data retrospectively obtained from electronic medical records which provided real and effective data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}